a proposito di comunicazione societaria....
in base a quanto postato sul FOL, bisognerebbe guardare il sito
Deka -> Deka Centre
e relative notizie... SE QUESTE FOSSERO POSTATE ABITUALMENTE DA EL.EN L'ATTENZIONE SUL TITOLO SAREBBE MOLTO PIU ALTA...
... non solo mercati che si aprono in continuazione, ma anche semplici articoli come quello postato meno di un mese fa
ITALIAN CO2 LASER CONQUERS THE WORLD:
1,000 LASERS SOLD AND 500,000 TREATMENTS PERFORMED
The Tuscan company DEKA confirms its market leadership in the medical laser sector
in Italy and in 70 countries including China, Japan and the USA.
Florence, Italy - 12 November 2015 – An Italian success story: DEKA, the leading Tuscan company for the design, production and
marketing of lasers and light systems for medical applications has, in little over 5 years, sold worldwide over 1,000 SmartXide2
CO2
laser systems, technology specifically designed for the MonaLisa Touch® treatment.
MonaLisa Touch®, the vaginal laser used against menopausal and post-partum disorders, was a major innovation for DEKA,
representing 40% of total revenues. The company aims to double sales for the next two years.
This significant target was reached thanks to the technological superiority and great versatility of the SmartXide2
which can be used
in various branches of medicine such as ENT, surgery, dermatology and gynaecology. In the gynaecology sector in particular, the
innovative laser represents a development in terms of effectiveness and safety and has revolutionised traditional medicine, especially
for the vulvo-vaginal problems typical during menopause.
“The product is the fruit of an intuition: applying a CO2
laser to the vaginal mucosa in order to replicate what usually happened
during fractional face treatment,” said Leonardo Masotti, DEKA President. “With MonaLisa Touch® we were able to actualise this
idea and have created a unique technology among its kind. Our aim for the future is to offer permanent solutions to women with
gynaecological problems or problems related to menopause, developing practical synergies with hormone replacement therapy.”
In 2009, with SmartXide2
DEKA was the first company to present CO2
laser therapy in the V2
LR (Vulvo-Vaginal Laser Reshaping)
configuration applying DOT therapy to vulvo-vaginal treatments. Since then it has consolidated its leading position in Italy and
abroad.
Today the company is present in 70 countries including Central America, Latin America, Scandinavia, Poland, the Russian
Federation, Japan, Singapore, Malaysia and Australia and has recently reached new strategic markets: China and the USA.
“As well as the product’s uniqueness, the strength of the international success lies in having understood the cultural differences of
each country and thus in having positioned itself according to the social aspects and distinctive features that influence women of
each nation. In addition, the machine is certified for use in almost every country worldwide,” commented Mauro Galli, DEKA Export
Manager. “G
rowth prospects abroad are very promising and currently the USA is the largest market where, in a 6-month period only,
we have reached a significant quote of our global sales revenues.”
There have been over 500,000 treatments throughout the world demonstrating the effectiveness of the treatment. The CO2
laser
guarantees maximum safety of action and total control, eliminating every risk for patients.
“Unlike other types of lasers, the SmartXide2
CO2
laser can reach the right depth of action and the correct thermal effect to trigger the
cell regeneration process,” said Stefano Modi, DEKA Head of Research & Development. “The system uses an exclusive technology
(PSD Technology) which modulates the form of the laser pulse according to the tissue to be treated. This optimises the effectiveness
of the treatment and reduces the pain felt by the patient to the minimum.”
DEKA was incorporated in 1991 as a spin-off of the El.En. Group and has always brought developments and technological
innovation to the medical laser sector worldwide. DEKA was the first company to introduce systems for innovative applications,
which have been distributed globally. Today, thanks to the flexibility of laser applications, DEKA offers a unique range of solutions
in a variety of contexts: medicine and aesthetics, surgery, V2
LR - vulvo-vaginal laser reshaping, odontostomatology and laser therapy
......un po' di supporto agli azionisti sarebbe gradito
